Genetics of atherosclerosis

Annual Review of Genomics and Human Genetics

Volumn 5, Issue , 2004, Pages 189-218

  Lusis, Aldons J ^a,b   Mar, Rebecca ^a   Pajukanta, Päivi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; Lipoproteins; Myocardial infarction; Stroke

Indexed keywords

ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; GENETIC EPIDEMIOLOGY; GENETICS; HEART INFARCTION; HEREDITY; HUMAN; NONHUMAN; REVIEW; RISK FACTOR; STROKE;

ARTERIOSCLEROSIS; DIABETES COMPLICATIONS; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; RISK FACTORS;

ANIMALIA;

EID: 5444244817     PISSN: 15278204     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genom.5.061903.175930     Document Type: Review

References (106)

1. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, et al. 1999. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet. 21:76-83
2. Allayee H, Ghazalpour A, Lusis AJ. 2003. Using mice to dissect genetic factors in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23:1501-9
3. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, et al. 2000. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26:76-80
4. Benditt EP, Benditt JM. 1973. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. USA 70:1753-56
5. Bennett MR, Evan GI, Schwartz SM. 1995. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest. 95:2266-74
6. Berg K. 1989. Impact of medical genetics on research and practices in the area of cardiovascular disease. Clin. Genet. 36:299-312
7. Berg K. 1993. Lp(a) lipoprotein: an important genetic risk factor for atherosclerosis. In Molecular Genetics of Coronary Artery Disease, ed. AJ Lusis, JI Rotter, RS Sparkes, pp. 189-207. Basel, Switzerland: Karger
8. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, et al. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22:347-51
9. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. 1992. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J. Clin. Invest. 90:52-60
10. Botstein D, Risch N. 2003. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat. Genet. 33(Suppl.):228-37
11. Broeckel U, Hengstenberg C, Mayer B, Holmer S, Martin LJ, et al. 2002. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat. Genet. 30:210-14
12. Burris TP, Eacho PI, Cao G. 2002. Genetic disorders associated with ATP binding cassette cholesterol transporters. Mol. Genet. Metab. 77:13-20
13. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, et al. 1992. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-44
14. Caulfield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, et al. 1995. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J. Clin. Invest. 96:687-92
15. Colditz GA, Stampfer MJ, Willett WC, Rosner B, Speizer FE, Hennekens CH. 1986. A prospective study of parental history of myocardial infarction and coronary heart disease in women. Am. J. Epidemiol. 123:48-58
16. Dallinga-Thie GM, Bu XD, van Linde-Sibenius Trip M, Rotter JI, Lusis AJ, de Bruin TW. 1996. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III. J. Lipid Res. 37:136-47
17. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. 2001. High-resolution haplotype structure in the human genome. Nat. Genet. 29:229-32
18. DeMeester CA, Bu X, Gray RJ, Lusis AJ, Rotter JI. 1995. Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus. Am. J. Hum. Genet. 56:287-93
19. Dominiczak AF, McBride MW. 2003. Genetics of common polygenic stroke. Nat. Genet. 35:116-17
20. Drazen JM, Yandava CN, Dube L, Szczerback N, Hippensteel R, et al. 1999. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat. Genet. 22:168-70
21. Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, et al. 2004. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid and atherosclerosis in humans: The Los Angeles Heart Study. N. Engl. J. Med. 350:29-37
22. Elbein SC, Hoffman MD, Teng K, Leppert MF, Hasstedt SJ. 1999. A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes 48:1175-82
23. Elliott TG, Viberti G. 1993. Relationship between insulin resistance and coronary heart disease in diabetes mellitus and the general population: a critical appraisal. Baillieres Clin. Endocrinol. Metab. 7:1079-103
24. Faber BC, Heeneman S, Daemen MJ, Cleutjens KB. 2002. Genes potentially involved in plaque rupture. Curr Opin. Lipidol. 13:545-52
25. Francke S, Manraj M, Lacquemant C, Lecoeur C, Lepretre F, et al. 2001. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum. Mol. Genet. 10:2751-65
26. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, et al. 2002. The structure of haplotype blocks in the human genome. Science 296:2225-29
27. Goldbourt U, Neufeld HN. 1986. Genetic aspects of arteriosclerosis. Arteriosclerosis 6:357-77
28. Goldstein JL, Hobbs HH, Brown MS. 1995. Familial hypercholesterolemia. In The Metabolic Basis of Inherited Disease, ed. CR Scriver, AL Beaudet, WS Sly, D Valle, pp. 1267-82. New York: McGraw Hill
29. Gretarsdottir S, Thorleifsson G, Reynisdottir ST, Manolescu A, Jonsdottir S, et al. 2003. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat. Genet. 35:131-38
30. Hamsten A. 1993. The hemostatic system and coronary heart disease. Thromb. Res. 70:1-38
31. Han Z, Truong QA, Park S, Breslow JL. 2003. Two Hsp70 family members expressed in atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 100:1256-61
32. Hanson RL, Ehm MG, Pettitt DJ, Prochazka M, Thompson DB, et al. 1998. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am. J. Hum. Genet. 63:1130-38
33. Hegele RA, Zinman B, Hanley AJ, Harris SB, Barrett PH, Cao H. 2003. Genes, environment and Oji-Cree type 2 diabetes. Clin. Biochem. 36:163-70
34. Hopkins PN, Hunt SC, Wu LL, Williams GH, Williams RR. 1996. Hypertension, dyslipidemia, and insulin resistance: links in a chain or spokes on a wheel? Curr. Opin. Lipidol. 7:241-53
35. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, et al. 2000. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26:163-75
36. Hsueh WA. 2003. Introduction: new insight into understanding the relation of type 2 diabetes mellitus, insulin resistance, and cardiovascular disease. Am. J. Cardiol. 92:1J-2J
37. Humphries SE, Lane A, Dawson S, Green FR. 1992. The study of gene-environment interactions that influence thrombosis and fibrinolysis. Genetic variation at the loci for factor VII and plasminogen activator inhibitor-1. Arch. Pathol. Lab. Med. 116:1322-29
38. Ivandic BT, Qiao JH, Machleder D, Liao F, Drake TA, Lusis AJ. 1996. A locus on chromosome 7 determines myocardial cell necrosis and calcification (dystrophic cardiac calcinosis) in mice. Proc. Natl. Acad. Sci. USA 93:5483-88
39. Jee SH, Song KS, Shim WH, Kim HK, Sun I, et al. 2002. Major gene evidence after MTHFR-segregation analysis of serum homocysteine in families of patients undergoing coronary arteriography. Hum. Genet. 111:128-35
40. Jeffs B, Clark JS, Anderson NH, Gratton J, Brosnan MJ, et al. 1997. Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus. Nat. Genet. 16:364-67
41. Rang SS, Passen EL, Ruggie N, Wong PW, Sora H. 1993. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation 88:1463-69
42. Kaprio J, Norio R, Pesonen E, Sama S. 1993. Intimai thickening of the coronary arteries in infants in relation to family history of coronary artery disease. Circulation 87:1960-68
43. Keys A, Menotti A, Karvonen MJ, Aravanis C, Blackburn H, et al. 1986. The diet and 15-year death rate in the seven countries study. Am. J. Epidemiol. 124:903-15
44. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, et al. 2002. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347:185-92
45. King RA, Rotter JI, Motulsky AG. 2002. The Genetic Basis of Common Diseases. New York: Oxford Univ. Press
46. Krushkal J, Ferrell R, Mockrin SC, Turner ST, Sing CF, Boerwinkle E. 1999. Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation 99:1407-10
47. Leibel RL, Chua SC, Rosenbaum M. 2001. Obesity. In The Metabolic Basis of Inherited Disease, ed. CR Scriver, AL Beaudet, WS Sly, D Valle, pp. 3965-4027. New York: McGraw Hill
48. Liao F, Andalibi A, Qiao JH, Allayee H, Fogelman AM, Lusis AJ. 1994. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J. Clin. Invest. 94:877-84
49. Lifton RP, Gharavi AG, Geller DS. 2001. Molecular mechanisms of human hypertension. Cell 104:545-56
50. Lusis AJ. 2000. Atherosclerosis. Nature 407:233-41
51. Lusis AJ. 2003. Genetic factors in cardiovascular disease. 10 questions. Trends Cardiovasc. Med. 13:309-16
52. Lusis AJ, Weinreb A, Drake TA, Allayee H. 2002. Genetics of atherosclerosis. In Textbook of Cardiovascular Medicine, 2nd Edition, ed. E Topol. Philadelphia: Lippincott Williams and Wilkins
53. Lutgens E, Gijbels M, Smook M, Heeringa P, Gotwals P, et al. 2002. Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler. Thromb. Vasc. Biol. 22:975-82
54. Lyons TJ. 1993. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am. J. Cardiol. 71:26B-31B
55. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, et al. 1996. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 94:2410-16
56. Mehrabian M, Allayee H, Wong J, Shi W, Wang XP, et al. 2002. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ. Res. 91:120-26
57. Mitchell SM, Frayling TM. 2002. The role of transcription factors in maturity-onset diabetes of the young. Mol. Genet. Metab. 77:35-43
58. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, et al. 2003. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34:267-73
59. Motulsky AG. 1992. Nutrition and genetic susceptibility to common diseases. Am. J. Clin. Nutr. 55:12448-458
60. Motulsky AG, Brunzell JD. 2003. Genetics of coronary atherosclerosis. In The Genetic Basis of Common Disease, 2nd Edition, ed. RA King, JI Rotter, AG Motulsky, pp. 105-26. New York: Oxford Univ. Press
61. Nichaman MZ, Hamilton HB, Kagan A, Grier T, Sacks T, Syme SL. 1975. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: distribution of biochemical risk factors. Am. J. Epidemiol. 102:491-501
62. Norman RA, Bogardus C, Ravussin E. 1995. Linkage between obesity and a marker near the tumor necrosis factor-alpha locus in Pima Indians. J. Clin. Invest. 96:158-62
63. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, et al. 2002. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat. Genet. 32:650-54
64. Pajukanta P, Cargill M, Viitanen L, Nuotio I, Kareinen A, et al. 2000. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am. J. Hum. Genet. 67:1481-93
65. Pajukanta P, Lilja HE, Sinsheimer JS, Cantor RM, Lusis AJ, et al. 2004. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat. Genet. 36:371-76
66. Pajukanta P, Nuotio I, Terwilliger JD, Porkka KV, Ylitalo K, et al. 1998. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat. Genet. 18:369-73
67. Patil N, Berno AJ, Hinds DA, Barrett WA, Doshi JM, et al. 2001. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 294:1719-23
68. Qiao JH, Tripathi J, Mishra NK, Cai Y, Tripathi S, et al. 1997. Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. Am. J. Pathol. 150:1687-99
69. Qiao JH, Xie PZ, Fishbein MC, Kreuzer J, Drake TA, et al. 1994. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arterioscler. Thromb. 14:1480-97
70. Randi AM, Biguzzi E, Falciani F, Merlini P, Blakemore S, et al. 2003. Identification of differentially expressed genes in coronary atherosclerotic plaques from patients with stable or unstable angina by cDNA array analysis. J. Thromb. Haemost. 1:829-35
71. Reaven GM. 1988. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-607
72. Reich DE, Lander ES. 2001. On the allelic spectrum of human disease. Trends Genet. 17:502-10
73. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, et al. 2001. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet. 29:223-28
74. Risch N, Merikangas K. 1996. The future of genetic studies of complex human diseases. Science 273:1516-17
75. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, et al. 1994. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 91:3662-65
76. Rust S, Rosier M, Funke H, Real J, Amoura Z, et al. 1999. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22:352-55
77. Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, et al. 2003. Genetics of gene expression surveyed in maize, mouse and man. Nature 422:297-302
78. Schildkraut JM, Myers RH, Cupples LA, Kiely DK, Kannel WB. 1989. Coronary risk associated with age and sex of parental heart disease in the Framingham Study. Am. J. Cardiol 64:555-59
79. Schreyer SA, Vick CM, LeBoeuf RC. 2002. Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice. J. Biol. Chem. 277:12364-68
80. Schwartz SM, Murry CE. 1998. Proliferation and the monoclonal origins of atherosclerotic lesions. Annu. Rev. Med. 49:437-60
81. Shi W, Haberland ME, Jien ML, Shin DM, Lusis AJ. 2000. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation 102:75-81
82. Shi W, Wang NJ, Shih DM, Sun VZ, Wang X, Lusis AJ. 2000. Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. Circ. Res. 86:1078-84
83. Shi W, Wang X, Tangchitpiyanond K, Wong J, Shi Y, Lusis AJ. 2002. Atherosclerosis in C3H/HeJ mice reconstituted with apolipoprotein E-null bone marrow. Arterioscler. Thromb. Vasc. Biol. 22:650-55
84. Shih DM, Reddy S, Lusis AJ. 2001. CHD and atherosclerosis: human epidemiological studies and trangenic mouse models. In Paraoxonase (PON1) in Health and Disease, ed. LG Costa, C Furlong. Boston: Kluwer
85. Shimada K, Watanabe Y, Mokuno H, Iwama Y, Daida H, Yamaguchi H. 2000. Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men. Am. J. Cardiol. 86:682-84, A8
86. Shohet RV, Vega GL, Bersot TP, Mahley RW, Grundy SM, et al. 2002. Sources of variability in genetic association studies: insights from the analysis of hepatic lipase (LIPC). Hum. Mutat. 19:536-42
87. Sing CF, Davignon J. 1985. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am. J. Hum. Genet. 37:268-85
88. Sing CF, Stengard JH, Kardia SL. 2003. Genes, environment, and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 23:1190-96
89. Slack J, Evans KA. 1966. The increased risk of death from ischaemic heart disease in first degree relatives of 121 men and 96 women with ischaemic heart disease. J. Med. Genet. 2:239-57
90. Smith DJ, Lusis AJ. 2002. The allelic structure of common disease. Hum. Mol. Genet. 11:2455-61
91. Spiegelman BM, Flier JS. 1996. Adipogenesis and obesity: rounding out the big picture. Cell 87:377-89
92. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, et al. 1997. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J. Hypertens. 15:1579-92
93. Talmud PJ, Hawe E, Martin S, Olivier M, Miller GJ, et-al. 2002. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum. Mol. Genet. 11:3039-46
94. Thomas AE, Green FR, Lamlum H, Humphries SE. 1995. The association of combined alpha and beta fibrinogen genotype on plasma fibrinogen levels in smokers and non-smokers. J. Med. Genet. 32:585-89
95. Topol EJ, McCarthy J, Gabriel S, Moliterno DJ, Rogers WJ, et al. 2001. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation 104:2641-44
96. Tournier-Lasserve E. 2002. New players in the genetics of stroke. N. Engl. J. Med. 347:1711-12
97. Tward A, Xia YR, Wang XP, Shi YS, Park C, et al. 2002. Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation 106:484-90
98. Utermann G, Pruin N, Steinmetz A. 1979. Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin. Genet. 15:63-72
99. Vionnet N, Hani El H, Dupont S, Gallina S, Francke S, et al. 2000. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am. J. Hum. Genet. 67:1470-80
100. Wall JD, Pritchard JK. 2003. Assessing the performance of the haplotype block model of linkage disequilibrium. Am. J. Hum. Genet. 73:502-15
101. Wang L, Fan C, Topol SE, Topol EJ, Wang Q. 2003. Mutation in MEF2A in an inherited disorder with features of coronary artery disease. Science 302:1578-81
102. Wang Q, Rao S, Shen G-Q, Li L, Moliterno DJ, et al. 2004. Premature myocardial infarction novel susceptibility locus on chromosome 1p34-36 identified by genome-wide linkage analysis. Am. J. Hum. Genet. 74:262-71
103. Wang X, Paigen B. 2002. Quantitative trait loci and candidate genes regulating HDL cholesterol: a murine chromosome map. Arterioscler. Thromb. Vasc. Biol. 22:1390-401
104. Warden CH, Daluiski A, Bu X, Purcell-Huynh DA, De Meester C, et al. 1993. Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans. Proc. Natl. Acad. Sci. USA 90:10886-90
105. Wiltshire S, Hattersley AT, Hitman GA, Walker M, Levy JC, et al. 2001. A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am. J. Hum. Genet. 69:553-69
106. Zhang K, Sun F, Waterman MS, Chen T. 2003. Haplotype block partition with limited resources and applications to human chromosome 21 haplotype data. Am. J. Hum. Genet. 73:63-73